Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery

HK Chan, A Clark, I Gonda, M Mumenthaler… - Pharmaceutical …, 1997 - Springer
Purpose. We have used rhDNase to investigate the feasibility of developing a dry protein
powder aerosol for inhalation delivery. Methods. Powders of rhDNase alone and with sodium …

The ascent of pulmonary drug delivery

I Gonda - Journal of pharmaceutical sciences, 2000 - Elsevier
The origins of inhalation therapy can be traced back to the early civilizations but this route of
administration was relatively uncommon until recently. Direct delivery of drugs to the lung by …

Liposomal formulations for inhalation

D Cipolla, I Gonda, HK Chan - Therapeutic delivery, 2013 - Future Science
No marketed inhaled products currently use sustained release formulations such as liposomes
to enhance drug disposition in the lung, but that may soon change. This review focuses …

Droplets produced by medical nebulizers: some factors affecting their size and solute concentration

PR Phipps, B Pharm, I Gonda - Chest, 1990 - Elsevier
The effect of nebulizer solution temperature and dilution air humidity on the size and solute
concentration of aqueous aerosol droplets were studied. Four combinations of jet-nebulizers …

[HTML][HTML] Development of liposomal ciprofloxacin to treat lung infections

D Cipolla, J Blanchard, I Gonda - Pharmaceutics, 2016 - mdpi.com
Except for management of Pseudomonas aeruginosa (PA) in cystic fibrosis, there are no
approved inhaled antibiotic treatments for any other diseases or for infections from other …

Mathematical modeling of heat and water transport in human respiratory tract

E Daviskas, I Gonda… - Journal of Applied …, 1990 - journals.physiology.org
Excessive heat and water losses from the airways are stimuli to asthma. To study heat and
water vapor transport in the human respiratory tract, a time-dependent model, based on a …

Systemic delivery of drugs to humans via inhalation

I Gonda - Journal of Aerosol Medicine, 2006 - liebertpub.com
Unwanted systemic absorption of drugs delivered for the local treatment of respiratory
disease is well documented. Methods to minimize this now exist, especially for reduction of …

A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol

…, LT Rodwell, KIM Chan, I Gonda… - American journal of …, 1997 - atsjournals.org
We developed a bronchial provocation test (BPT) with a dry powder preparation of mannitol.
The mannitol was inhaled from gelatin capsules containing 5, 10, 20, or 40 mg to a …

[HTML][HTML] Nebulised isotonic hydroxychloroquine aerosols for potential treatment of COVID-19

W Tai, MYT Chow, RYK Chang, P Tang, I Gonda… - Pharmaceutics, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) is an unprecedented pandemic that has severely
impacted global public health and the economy. Hydroxychloroquine administered orally to …

Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial

…, HW Greville, D Cipolla, P Bruinenberg, I Gonda… - Thorax, 2013 - thorax.bmj.com
Background The delivery of antipseudomonal antibiotics by inhalation to Pseudomonas
aeruginosa-infected subjects with non-cystic fibrosis (CF) bronchiectasis is a logical extension of …